Log in to save to my catalogue

Metabolic effects of troglitazone therapy in type 2 diabetic, obese, and lean normal subjects

Metabolic effects of troglitazone therapy in type 2 diabetic, obese, and lean normal subjects

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_gale_infotracgeneralonefile_A59175306

Metabolic effects of troglitazone therapy in type 2 diabetic, obese, and lean normal subjects

About this item

Full title

Metabolic effects of troglitazone therapy in type 2 diabetic, obese, and lean normal subjects

Publisher

United States: American Diabetes Association

Journal title

Diabetes care, 2000-01, Vol.23 (1), p.64-69

Language

English

Formats

Publication information

Publisher

United States: American Diabetes Association

More information

Scope and Contents

Contents

Metabolic effects of troglitazone therapy in type 2 diabetic, obese, and lean normal subjects.
J P Frias ,
J G Yu ,
Y T Kruszynska and
J M Olefsky
Division of Endocrinology and Metabolism, University of California, San Diego, La Jolla 92093, USA.
Abstract
OBJECTIVE: To characterize metabolic effects of troglitazone in type 2 di...

Alternative Titles

Full title

Metabolic effects of troglitazone therapy in type 2 diabetic, obese, and lean normal subjects

Authors, Artists and Contributors

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_gale_infotracgeneralonefile_A59175306

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_gale_infotracgeneralonefile_A59175306

Other Identifiers

ISSN

0149-5992

E-ISSN

1935-5548

DOI

10.2337/diacare.23.1.64

How to access this item